NDAORALTABLET
Approved
Apr 2009
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
5/8 — Partial
EXFORGE HCT (amlodipine valsartan and hydrochlorothiazide) by Novartis is angiotensin 2 receptor antagonists [moa]. Approved for thiazide diuretic [epc]. First approved in 2009.
Drug data last refreshed 2d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
EXFORGE HCT is a fixed-dose triple-combination oral tablet combining amlodipine (calcium channel blocker), valsartan (angiotensin II receptor antagonist), and hydrochlorothiazide (thiazide diuretic) approved in 2009. It is indicated for hypertension management in patients requiring multi-agent therapy. The combination works through complementary mechanisms: amlodipine and valsartan inhibit vasoconstriction while hydrochlorothiazide reduces fluid volume.
$0.988MPart D
LOE ApproachingDeclining
Declining spending and low claim volume signal a contracting brand team with focus shifting to transition planning rather than growth initiatives.
Mechanism of Action
Angiotensin 2 Receptor Antagonists
Pharmacologic Class:
Thiazide Diuretic
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Zero linked job count and undefined top roles indicate minimal active hiring or team expansion for EXFORGE HCT. Employment prospects are limited; careers on this product are typically in maintenance/transition roles rather than growth-oriented positions.
Company
Worked on EXFORGE HCT at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.